Historical record - last NADAC effective date: 1/22/2020
Product Information
TAMIFLU 45 MG CAPSULE is a brand product labeled by Genentech, Inc., priced at $13.5402 per EA under NDC 00004080185. Its NADAC has been published 373 times since Nov 28, 2013.
FDA first approved this application on Oct 27, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the oseltamivir phosphate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
45 mg/1
Manufacturer
Genentech, Inc.NDC
00004080185
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
1/22/2020
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA021087FDA Approved
10/27/1999
TE Code
AB
On Market Since
10/27/1999
Pharmacological Classes
Price Statistics
The NADAC for TAMIFLU 45 MG CAPSULE has been published 373 times since Nov 28, 2013, and over the history we have for it it has risen 36.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.5402 per EA |
|---|---|
| All-time high | $13.5402 (Jan 13, 2021) |
| All-time low | $9.4237 (Jun 18, 2014) |
| Median price | $12.7899 |
| Average price | $12.3872 |
| Largest weekly change | +9.0% (Jul 9, 2014) |
| Weeks tracked | 373 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+36.4%
Last surveyed Jan 13, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TAMIFLU 45 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TAMIFLU 45 MG CAPSULE, manufactured by Genentech, Inc., is $13.5402 per EA (NDC 00004080185), effective Jan 13, 2021.
How has the price of TAMIFLU 45 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TAMIFLU 45 MG CAPSULE has risen 36.4%. It has been tracked across 373 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TAMIFLU 45 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TAMIFLU 45 MG CAPSULE has ranged from a low of $9.4237 (Jun 18, 2014) to a high of $13.5402 (Jan 13, 2021), with a median of $12.7899 per EA.
Are there cheaper alternatives to TAMIFLU 45 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OSELTAMIVIR PHOS 45 MG CAPSULE, is $0.7693 per EA — about 94% below TAMIFLU 45 MG CAPSULE.
Who manufactures TAMIFLU 45 MG CAPSULE?
TAMIFLU 45 MG CAPSULE (NDC 00004080185) is labeled by Genentech, Inc., and CMS classifies it as a brand product.